Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Indonesian Journal of Cardiology
Bagaswoto, H. P.
Unknown Affiliation
Health Professions Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Cardiogenic Shock Bagaswoto, H. P.; Juzar, D. A.; Habib, F.; Bramantyo, Y. S.; Sanggula, P. N. P. P.; Widiastuti, A. Z.
Jurnal Kardiologi Indonesia Vol 43 No 2 (2022): Indonesian Journal of Cardiology: April - June 2022
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1505

Abstract

Cardiogenic shock (CS) is the most common cause of death in hospitalized patients with acute myocardial infarction (AMI). The incidence and mortality of CS in hospitals is also high, although advanced therapy is widely used in CS patients. CS is a condition characterized by inadequate cardiac output due to primary cardiovascular diseases, leading to clinical and biochemical manifestations of insufficient tissue perfusion. CS complicates 5–10% of AMI. STEMI increases the risk of CS approximately twice as much as NSTEMI. In the last 10 years, in-hospital mortality due to CS that occurs in AMI has not changed, that is at 40-50%. The pathophysiology of CS shows several overlaps and can occur simultaneously, that is starting with a cardiac insult that reduces cardiac output, central hemodynamic changes, microcirculatory dysfunction, systemic inflammatory response syndrome, and multi-organ dysfunction. CS classification based on SCAI, divided into 5, that’s A(at risk), B(beginning CS), C(classic CS), D(deteriorating), and E(extremis). The key to managing CS is treating the patient as soon as possible, as each higher SCAI shock stage was associated with increased hospital mortality. All patients with suspected ACS-associated CS should have an early invasive strategy with appropriate revascularization. Vasoactive medicines have the potential to improve hemodynamics but at the expense of increased myocardial oxygen consumption and arrhythmogenic risk. Mechanical circulatory support (MCS) has insufficient data as the first-line device solution for CS patients. However, the use of durable MCS devices in a bridge-to-bridge strategy is becoming more prevalent and is supported by clinical recommendations. APACHE-III and SAPS-II, had the best mortality discrimination values to assess the outcome in CS patients.
Cardiogenic Shock Bagaswoto, H. P.; Juzar, D. A.; Habib, F.; Bramantyo, Y. S.; Sanggula, P. N. P. P.; Widiastuti, A. Z.
Jurnal Kardiologi Indonesia Vol 46 No 4 (2025): October - December, 2025
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.2035

Abstract

In “Cardiogenic Shock” (Indonesian Journal of Cardiology, 43(2), 90-9. https://doi.org/10.30701/ijc.1505), there are an errors noted. An error has been found in the PDF version of this article. The DOI printed in the PDF is incorrect. The correct DOI is https://doi.org/10.30701/ijc.1505. The error occurs only in the PDF; the DOI listed in the article metadata is already correct. An error also appears in the affiliations section. In the original article, the affiliations were incorrectly listed as:[1] Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada - Sardjito General Hospital, Yogyakarta[2] Faculty of Medicine, Universitas Indonesia - National Cardiovascular Center Harapan Kita, Jakarta[3] Faculty of Medicine, Universitas Sumatera Utara - Adam Malik General Hospital, Medan[4] Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta The affiliations have been corrected to:[1] Department of Cardiology and Vacular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada - Sardjito General Hospital, Yogyakarta, Indonesia[2] Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia - National Cardiovascular Center Harapan Kita, Jakarta, Indonesia[3] Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Sumatera Utara - Adam Malik General Hospital, Medan, Indonesia[4] Cardiology Research Office, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia The publisher apologizes for any inconvenience caused by this error. DOI of original article: https://doi.org/10.30701/ijc.1505
Co-Authors Bramantyo, Y. S. Habib, F. Juzar, D. A. Sanggula, P. N. P. P. Widiastuti, A. Z.